All data are based on the daily closing price as of July 18, 2025
o
Olympus
7733.TSE
11.58 USD
0.02
+0.17%
Overview
Last close
11.58 usd
Market cap
13.07B usd
52 week high
19.88 usd
52 week low
11.24 usd
Target price
15.93 usd
Valuation
P/E
16.751
Forward P/E
17.6367
Price/Sales
1.9476
Price/Book Value
2.5839
Enterprise Value
12.88B usd
EV/Revenue
1.9218
EV/EBITDA
8.2485
Key financials
Revenue TTM
6.70B usd
Gross Profit TTM
4.59B usd
EBITDA TTM
1.57B usd
Earnings per Share
0.69 usd
Dividend
0.13 usd
Total assets
9.61B usd
Net debt
-157.15M usd
About
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.